Amyloid-beta 1-40
peptideAmyloid-beta 1-40 destabilizes atherosclerotic plaques by promoting matrix degradation, precipitating rupture and thrombosis.
Pathway placement
Cascade stepFibrous-cap degradation & rupture
Confidencemedium
RationalePlaque destabilization and mortality predictor in NSTE-ACS; promotes fibrous-cap degradation.
Also acts inPlatelet activation
Druggability
Not assessed (no mapped human gene target).
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Plasma (EDTA; peptidase-labile — chilled + protease inhibitor)
Collection tube
K2-EDTA, chilled plastic (lavender-top) · Serum separator (gold/red-top, SST)
Method / principle
Competitive/sandwich immunoassay or LC-MS/MS
Reagent / substrate
Anti-peptide antibody; or isotope-labeled internal standard (MS)
Platform
Immunoassay / LC-MS/MS
Turnaround · availability
Send-out / research · Research-grade
Literature evidence(1)
- Amyloid-β (1-40) and Mortality in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: A Cohort Study.Annals of internal medicine · 2018 · PMID 29799975 · doi